Foldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced positive 30-day results from a...
Read moreActuate Therapeutics plans to sell nearly 5.56 million shares at between $8 and $10 apiece in its initial public...
Read morePteroDynamics Inc., an innovator in autonomous vertical takeoff and landing (VTOL) aircraft systems, today announced that Joshua Roth has...
Read moreResearchers at Neuro-Bio Ltd in collaboration with an international team of clinicians and neuroscientists have published a new perspective...
Read moreActuate Therapeutics, a Phase 2 biotech developing in-licensed inhibitor therapies for difficult to treat cancers, filed on Friday with...
Read moreMemVerge in collaboration with Micron and SuperMicro showcased a remarkable breakthrough in computing at Nvidia’s GTC conference. MemVerge demonstrated...
Read moreVivodyne, a pioneering biotech company that grows and tests on lab-grown human tissues to accelerate therapeutics discovery and development,...
Read moreClearsense, a PaaS company that partners with healthcare organizations to increase data value, governance, and transparency, today announced it...
Read moreFoldax®, Inc., a leader in the development of innovative, polymer heart valves, today announced that its TRIA valves have...
Read moreLinnaeus Therapeutics, Inc., a Kairos portfolio company focused on the development and commercialization of novel small molecule oncology therapeutics, today...
Read more